Jure Murgic

Zagreb, Croatia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications

Immune landscape of muscle-invasive bladder cancer: role of TIGIT, LAG-3, and PD-L1.

Immune landscape of muscle-invasive bladder cancer: role of TIGIT, LAG-3, and PD-L1.

Journal: Frontiers in immunology
Published: December 29, 2025

Circulating microRNAs in prostate cancer - Non-invasive biomarkers for diagnosis, prognosis and therapy: A review.

Circulating microRNAs in prostate cancer - Non-invasive biomarkers for diagnosis, prognosis and therapy: A review.

Journal: Biomolecules & biomedicine
Published: July 24, 2025

Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study.

Updated results of MR-assisted focal salvage HDR prostate brachytherapy: a prospective study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: June 06, 2025

Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes.

Response and Survival With Immune Checkpoint Inhibitor in Patients With Advanced Urothelial Carcinoma and Histology Subtypes.

Journal: Clinical genitourinary cancer
Published: February 11, 2025

Complex Decision Making for Individual Patients With Penile Cancer: Benchmarking Divergent Practices in European High-Volume Reference Centers: Results From eUROGEN Survey.

Complex Decision Making for Individual Patients With Penile Cancer: Benchmarking Divergent Practices in European High-Volume Reference Centers: Results From eUROGEN Survey.

Journal: Clinical genitourinary cancer
Published: September 13, 2024

Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor.

Association of Tumor Mutational Burden and Microsatellite Instability With Response and Outcomes in Patients With Urothelial Carcinoma Treated With Immune Checkpoint Inhibitor.

Journal: Clinical genitourinary cancer
Published: April 08, 2024

Exploring potential therapeutic combinations for castration-sensitive prostate cancer using supercomputers: a proof of concept study.

Exploring potential therapeutic combinations for castration-sensitive prostate cancer using supercomputers: a proof of concept study.

Journal: Scientific reports
Published: March 10, 2024

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.

Response and Outcomes of Maintenance Avelumab After Platinum-Based Chemotherapy (PBC) in Patients With Advanced Urothelial Carcinoma (aUC): "Real World" Experience.

Journal: Clinical genitourinary cancer
Published: May 29, 2023

Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16.

Molecular classification of muscle-invasive bladder cancer based on a simplified immunohistochemical panel using GATA3, CK5/6 and p16.

Journal: Biomolecules & biomedicine
Published: May 02, 2023

RECENT ADVANCES IN RADIOTHERAPY MODALITIES FOR PROSTATE CANCER.

RECENT ADVANCES IN RADIOTHERAPY MODALITIES FOR PROSTATE CANCER.

Journal: Acta clinica Croatica
Published: March 20, 2023

DOSIMETRIC VERIFICATION OF INTENSITY MODULATED RADIOTHERAPY (IMRT) TREATMENT PLANS FOR PROSTATE CANCER PATIENTS.

DOSIMETRIC VERIFICATION OF INTENSITY MODULATED RADIOTHERAPY (IMRT) TREATMENT PLANS FOR PROSTATE CANCER PATIENTS.

Journal: Acta clinica Croatica
Published: March 20, 2023

MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM.

MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM.

Journal: Acta clinica Croatica
Published: March 20, 2023
Showing 1-12 of 54

Last Updated: 09/26/2026